Evaluation of the Insulin-like Growth Factor Receptor Pathway in Patients with Advanced Breast Cancer Treated with Trastuzumab

Background: Trastuzumab is a monoclonal antibody against HER2-positive breast cancer. Despite improving the natural history of the disease, there is a number of patients who are resistant to it, whereas all patients will eventually develop resistance and disease will progress. Inconsistent preclinic...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Genomics Proteomics
Autori principali: CHRISTODOULOU, CHRISTOS, OIKONOMOPOULOS, GEORGIOS, KOLIOU, GEORGIA ANGELIKI, KOSTOPOULOS, IOANNIS, KOTOULA, VASSILIKI, BOBOS, MATTHEOS, PENTHEROUDAKIS, GEORGE, LAZARIDIS, GEORGE, SKONDRA, MARIA, CHRISAFI, SOFIA, KOUTRAS, ANGELOS, BAFALOUKOS, DIMITRIOS, RAZIS, EVANGELIA, PAPADOPOULOU, KYRIAKI, PAPAKOSTAS, PAVLOS, KALOFONOS, HARALAMBOS P, PECTASIDES, DIMITRIOS, SKARLOS, PANTELIS, KALOGERAS, KONSTANTINE T, FOUNTZILAS, GEORGE
Natura: Artigo
Lingua:Inglês
Pubblicazione: International Institute of Anticancer Research 2018
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6299784/
https://ncbi.nlm.nih.gov/pubmed/30343280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/cgp.20105
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi